AzTrials
AzTrials

Traumatic Brain InjuryEcho-TCNCT02380482

Myocardial Dysfunction at Early Phase of Traumatic Brain Injury : Evaluation by Two Dimensional and Speckle Tracking Transthoracic Echocardiography

A study testing Transthoracic echocardiography on TBI patients in people with Traumatic Brain Injury, run by University Hospital, Grenoble at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Traumatic brain injury (TBI) is a frequent pathology leading to major morbidity and mortality in young people. Cerebral flood flow maintenance is a major goal directed therapy to improve the prognosis of the patient. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Traumatic Brain Injury
What is being tested?
Transthoracic echocardiography on TBI patients
Type of treatment
Injection or infusion
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteFrance
Study dates
Dec 2014to Oct 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Isolated and non opened traumatic brain injury
  • 18 - 65 years old
  • Intubated and mechanically ventilated
  • Glasgow score < or = 9 or
  • Glasgow score between 9 and 13 (included) and Following Traumatic Coma Data Bank Tomographic Damages diffuse injuries type III or IV or mass lesion over 25ml and/or neurosurgical injuries
  • Medical insurance
Show all 12Show fewer
  • Isolated and non opened traumatic brain injury
  • 18 - 65 years old
  • Intubated and mechanically ventilated
  • Paired with TBI patient on age, BMI and sex
  • Undergoing urgent non severe surgery
  • Medical insurance

Who cannot join

  • Treated major cardiovascular risks factors
  • cardiovascular past medical history (acute cardiovascular event)
  • Cardio thoracic surgery
  • Brain dead status
  • Inotrope drugs
  • Severe polytraumatism
Show all 24Show fewer
  • Acute haemorrhage
  • Non echogenic patient
  • High level athlete
  • Incapacitated person by law and pregnant women
  • Discovery during echocardiography of underlying cardiomyopathy
  • Urgent neurosurgery required
  • Control patients
  • Traumatic brain injury
  • Treated major cardiovascular risks factors
  • cardiovascular past medical history (acute cardiovascular event)
  • Cardio thoracic surgery
  • Inotrope and vasopressive drugs
  • Circulatory failure
  • Non echogenic patient
  • High level athlete
  • Incapacitated person by law and pregnant women
  • Discovery during echocardiography of underlying cardiomyopathy
  • Urgent neurosurgery required

Trial locations and contacts

1 site in 1 country.

France1 site
  • University hospital

    Grenoble, 38043

Other trials in France

About this study

Traumatic brain injury (TBI) is a frequent pathology leading to major morbidity and mortality in young people. Cerebral flood flow maintenance is a major goal directed therapy to improve the prognosis of the patient. Due to cerebral-myocardial interaction, a myocardial dysfunction might occur at the early phase of the traumatic brain injury. This myocardial dysfunction could be partly responsible for a decrease in cerebral blood flow. In such case, improving myocardial dysfunction may help to increase cerebral blood flow and improve patient prognosis. In clinical practice the easiest and non invasive way to explore myocardial dysfunction is with transthoracic echocardiography. The objective of this trial is to investigate myocardial dysfunction at the early phase of traumatic brain injury, compared with a controlled group without TBI.

Being tested
Transthoracic echocardiography on TBI patients, Transthoracic echocardiography on control patients
Keywords
Traumatic brain injury, Myocardial dysfunction, Transthoracic echocardiography, Speckle tracking
Medical subject headings
Brain Injuries, Traumatic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Transthoracic echocardiography on TBI patientsOther

    Two Dimensional and speckle trackingTransthoracic echocardiography on TBI patients within 24 hours of trauma

  • Transthoracic echocardiography on control patientsOther

    Two Dimensional and speckle trackingTransthoracic echocardiography on control patients while intubated-ventilated

Study groups in NCT02380482
Study groupRoleWhat they receive
Traumatic brain injuryOtherTwo dimensional and speckle tracking transthoracic echocardiography in traumatic brain injured patients * Glasgow score < or = 9 or * Glasgow score between 9 and 13 (included) and Following Traumatic Coma Data Bank Tomographic Damages: diffuse injuries type III or IV or mass lesion over 25ml and/or neurosurgical injuries
Receives: Other: Transthoracic echocardiography on TBI patients
ControlsOtherTwo dimensional and speckle tracking transthoracic echocardiography in control patients paired with traumatic brain injured patient on age, BMI and sex with the following criteria: * Intubated and mechanically ventilated * Undergoing urgent non severe surgery
Receives: Other: Transthoracic echocardiography on control patients

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. left ventricular ejection fraction

    Measured: within the first 24 hours after injury

Secondary outcomes (13)
  1. Strain evaluation by speckle tracking (in percentage of systolic duration)

    Measured: within the first 24 hours after injury

  2. Systolic strain rate by speckle tracking (in second)

    Measured: within the first 24 hours after injury

  3. Diastolic strain rate by speckle tracking (in second)

    Measured: within the first 24 hours after injury

  4. Systolic rotational velocity by speckle tracking (in degree by second)

    Measured: within the first 24 hours after injury

  5. Diastolic rotational velocity by speckle tracking (in degree by second)

    Measured: within the first 24 hours after injury

  6. Systolic twisting velocity by speckle tracking (in degree by second)

    Measured: within the first 24 hours after injury

  7. Diastolic untwisting velocity by speckle tracking (in degree by second)

    Measured: within the first 24 hours after injury

  8. Myocardial wall thickness (in millimeter)

    2D transthoracic echography

    Measured: within the first 24 hours after injury

  9. left ventricular diastolic function (cm/sec)

    2D transthoracic echography

    Measured: within the first 24 hours after injury

  10. Cardiac index

    2D transthoracic echography

    Measured: within the first 24 hours after injury

  11. tissue doppler imaging (cm/sec)

    2D transthoracic echography

    Measured: within the first 24 hours after injury

  12. right ventricular diastolic function

    2D transthoracic echography

    Measured: within the first 24 hours after injury

  13. right ventricular systolic function

    2D transthoracic echography

    Measured: within the first 24 hours after injury

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Mar 2015 (estimated)
  2. Study startDec 2014
  3. Primary completionSep 2015
  4. Study completionOct 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02380482
Sponsor's protocol ID
Echo-TC
Acronym
Echo-TC
Status last verified
Dec 2015
First submitted
23 Feb 2015
Last updated
9 Dec 2015
Results posted
No
Data monitoring committee
No

Publications

  • Bahloul M, Chaari AN, Kallel H, Khabir A, Ayadi A, Charfeddine H, Hergafi L, Chaari AD, Chelly HE, Ben Hamida C, Rekik N, Bouaziz M. Neurogenic pulmonary edema due to traumatic brain injury: evidence of cardiac dysfunction. Am J Crit Care. 2006 Sep;15(5):462-70.

    PubMed 16926367
  • Eagle KA, Berger PB, Calkins H, Chaitman BR, Ewy GA, Fleischmann KE, Fleisher LA, Froehlich JB, Gusberg RJ, Leppo JA, Ryan T, Schlant RC, Winters WL Jr, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Jacobs AK, Hiratzka LF, Russell RO, Smith SC Jr; American College of Cardiology; American Heart Association. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol. 2002 Feb 6;39(3):542-53. doi: 10.1016/s0735-1097(01)01788-0. No abstract available.

    PubMed 11823097
  • Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ; Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005 Dec;18(12):1440-63. doi: 10.1016/j.echo.2005.10.005. No abstract available.

    PubMed 16376782
  • Mor-Avi V, Lang RM, Badano LP, Belohlavek M, Cardim NM, Derumeaux G, Galderisi M, Marwick T, Nagueh SF, Sengupta PP, Sicari R, Smiseth OA, Smulevitz B, Takeuchi M, Thomas JD, Vannan M, Voigt JU, Zamorano JL. Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography. J Am Soc Echocardiogr. 2011 Mar;24(3):277-313. doi: 10.1016/j.echo.2011.01.015.

    PubMed 21338865
  • Moussouttas M, Lai EW, Khoury J, Huynh TT, Dombrowski K, Pacak K. Determinants of central sympathetic activation in spontaneous primary subarachnoid hemorrhage. Neurocrit Care. 2012 Jun;16(3):381-8. doi: 10.1007/s12028-012-9673-5.

    PubMed 22311230
  • Prathep S, Sharma D, Hallman M, Joffe A, Krishnamoorthy V, Mackensen GB, Vavilala MS. Preliminary report on cardiac dysfunction after isolated traumatic brain injury. Crit Care Med. 2014 Jan;42(1):142-7. doi: 10.1097/CCM.0b013e318298a890.

    PubMed 23963125
  • Rosenthal G, Hemphill JC 3rd, Sorani M, Martin C, Morabito D, Obrist WD, Manley GT. Brain tissue oxygen tension is more indicative of oxygen diffusion than oxygen delivery and metabolism in patients with traumatic brain injury. Crit Care Med. 2008 Jun;36(6):1917-24. doi: 10.1097/CCM.0b013e3181743d77.

    PubMed 18496376
  • Schrader H, Hall C, Zwetnow NN. Effects of prolonged supratentorial mass expansion on regional blood flow and cardiovascular parameters during the Cushing response. Acta Neurol Scand. 1985 Sep;72(3):283-94. doi: 10.1111/j.1600-0404.1985.tb00872.x.

    PubMed 4061050
  • Shanlin RJ, Sole MJ, Rahimifar M, Tator CH, Factor SM. Increased intracranial pressure elicits hypertension, increased sympathetic activity, electrocardiographic abnormalities and myocardial damage in rats. J Am Coll Cardiol. 1988 Sep;12(3):727-36. doi: 10.1016/s0735-1097(88)80065-2.

    PubMed 3403832
  • Shivalkar B, Van Loon J, Wieland W, Tjandra-Maga TB, Borgers M, Plets C, Flameng W. Variable effects of explosive or gradual increase of intracranial pressure on myocardial structure and function. Circulation. 1993 Jan;87(1):230-9. doi: 10.1161/01.cir.87.1.230.

    PubMed 8419012
  • Song HS, Back JH, Jin DK, Chung PW, Moon HS, Suh BC, Kim YB, Kim BM, Woo HY, Lee YT, Park KY. Cardiac troponin T elevation after stroke: relationships between elevated serum troponin T, stroke location, and prognosis. J Clin Neurol. 2008 Jun;4(2):75-83. doi: 10.3988/jcn.2008.4.2.75. Epub 2008 Jun 20.

    PubMed 19513307
  • Sosin DM, Sniezek JE, Waxweiler RJ. Trends in death associated with traumatic brain injury, 1979 through 1992. Success and failure. JAMA. 1995 Jun 14;273(22):1778-80.

    PubMed 7769773
  • Cuisinier A, Maufrais C, Payen JF, Nottin S, Walther G, Bouzat P. Myocardial function at the early phase of traumatic brain injury: a prospective controlled study. Scand J Trauma Resusc Emerg Med. 2016 Oct 28;24(1):129. doi: 10.1186/s13049-016-0323-3.

    PubMed 27793208

Questions about this trial

What is this clinical trial studying?

A study testing Transthoracic echocardiography on TBI patients in people with Traumatic Brain Injury, run by University Hospital, Grenoble at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 12 inclusion and 24 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Dec 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

left ventricular ejection fraction (time frame: within the first 24 hours after injury). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02380482, which also lists 13 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Dec 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in